跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,058 条关于
“BofA Securities India”
全部
3,058
临床试验
952
药物
67
机构
142
资讯
1,897
去年
Biocon Launches ₹4,500 Crore QIP to Strengthen Balance Sheet and Reduce Debt
去年
Alnylam's Amvuttra Poised to Become First-Line ATTR-CM Treatment
去年
Denali Therapeutics' ALS Trial Fails to Meet Endpoints, BofA Adjusts Stock Target
去年
Oculis Price Target Increased by BofA Following Promising Phase 2 Trial Results
去年
Vertex Pharmaceuticals Faces Securities Fraud Investigation After Disappointing Suzatrigine Trial Results
去年
Novo Nordisk's High-Dose Semaglutide Shows Promising Weight Loss Results in Phase 3b Trial
去年
Serina Therapeutics and enVVeno Medical Each File $100M Mixed Securities Shelf
去年
Iovance CFO Resigns Amid Amtagvi Launch Struggles and Securities Fraud Investigation
去年
Exelixis Downgraded to Market Perform Despite Price Target Increase to $40
去年
Agios Pharmaceuticals Faces Securities Fraud Investigation Following FDA Delay of PYRUKYND Approval
第 1 页,共 190 页
上一页
下一页